Aminoacyl-tRNA-Charged Eukaryotic Elongation Factor 1A Is the Bona Fide Substrate for Legionella pneumophila Effector Glucosyltransferases by Tzivelekidis, Tina et al.
Aminoacyl-tRNA-Charged Eukaryotic Elongation Factor
1A Is the Bona Fide Substrate for Legionella
pneumophila Effector Glucosyltransferases
Tina Tzivelekidis
1,2., Thomas Jank
1., Corinna Pohl
3, Andreas Schlosser
4, Sabine Rospert
5, Charlotte R.
Knudsen
6, Marina V. Rodnina
3, Yury Belyi
7, Klaus Aktories
1*
1Institut fu ¨r Experimentelle und Klinische Pharmakologie und Toxikologie, Albert-Ludwigs-Universita ¨t, Freiburg, Germany, 2Fakulta ¨tf u ¨r Biologie, Albert-Ludwigs-
Universita ¨t Freiburg, Freiburg, Germany, 3Max-Planck-Institut fu ¨r biophysikalische Chemie, Go ¨ttingen, Germany, 4Zentrum fu ¨r Biosystemanalyse, Core Facility
Proteomics, Albert-Ludwigs-Universita ¨t Freiburg, Freiburg, Germany, 5Institut fu ¨r Biochemie und Mikrobiologie, ZBMZ, Albert-Ludwigs-Universita ¨t, Freiburg, Germany,
6Department of Molecular Biology, University of Aarhus, Aarhus, Denmark, 7Gamaleya Research Institute, Moscow, Russia
Abstract
Legionella pneumophila, which is the causative organism of Legionnaires disease, translocates numerous effector proteins
into the host cell cytosol by a type IV secretion system during infection. Among the most potent effector proteins of
Legionella are glucosyltransferases (Lgt’s), which selectively modify eukaryotic elongation factor (eEF) 1A at Ser-53 in the
GTP binding domain. Glucosylation results in inhibition of protein synthesis. Here we show that in vitro glucosylation of
yeast and mouse eEF1A by Lgt3 in the presence of the factors Phe-tRNA
Phe and GTP was enhanced 150 and 590-fold,
respectively. The glucosylation of eEF1A catalyzed by Lgt1 and 2 was increased about 70-fold. By comparison of uncharged
tRNA with two distinct aminoacyl-tRNAs (His-tRNA
His and Phe-tRNA
Phe) we could show that aminoacylation is crucial for Lgt-
catalyzed glucosylation. Aminoacyl-tRNA had no effect on the enzymatic properties of Lgt’s and did not enhance the
glucosylation rate of eEF1A truncation mutants, consisting of the GTPase domain only or of a 5 kDa peptide covering Ser-53
of eEF1A. Furthermore, binding of aminoacyl-tRNA to eEF1A was not altered by glucosylation. Taken together, our data
suggest that the ternary complex, consisting of eEF1A, aminoacyl-tRNA and GTP, is the bona fide substrate for Lgt’s.
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Introduction
Legionella pneumophila is responsible for severe pneumonia
referred to as Legionnaires disease [1]. The bacterium lives
ubiquitously in aquatic environments, where it invades and
replicates within protozoa [2]. Infection occurs predominantly
due to inhalation of contaminated water sources [3]. After
entering phagocytic host cells such as alveolar macrophages,
Legionella survives and replicates intracellularly [4]. To this end,
Legionella produces a plethora of effector proteins, which are
injected into the host cell cytosol via a type IVb secretion system
(Dot/Icm system) [5–7] to subvert the phagosome into a
specialized compartment known as ‘‘Legionella containing vacuole’’
(LCV) [8–10]. The LCV fails to enter the lysosomal degradative
pathway and rather generates an intracellular environment where
Legionella can replicate extensively. Bioinformatics, genetic and
reporter-fusion screens for Dot/Icm effector proteins of Legionella
identified .300 candidates [8,11–15]. Only a few were biochem-
ically validated and even less were characterized at the molecular
level [8]. Some of these effectors are known to target distinct
regulatory host cell factors such as GTPases or ATPases [16–23] in
order to transform the host cell into a replication permissive
environment [8]. A number of effectors interact with vesicles and
influence their maturation by altering phosphoinositides involved
in trafficking and regulation [24]. However, most effector targets
remain elusive.
Among the best-studied effectors are members of the Legionella
glucosyltransferase family (Lgt) [25,26]. Pathogenic strains of L.
pneumophila possess up to three Lgt isoforms (Lgt1- 3) [27].
Unfortunately, data describing lgt-deletion strains concerning
intracellular replication or phenotypic alteration are lacking.
Recently, the crystal structure of Lgt1 was solved independently
by two groups [28,29]. Lgt1 exhibits a typical glucosyltransferase
GT-A type of fold with a central UDP-glucose binding domain,
sharing significant similarity with the glucosyltransferase domain
of Clostridium difficile toxins A and B [26,30]. Inside the host cell,
Lgt’s modify eukaryotic elongation factor 1A (eEF1A) by mono-O-
glucosylation and thereby inhibit protein synthesis. It has been
suggested that inhibition of protein synthesis of host cells by Lgt’s
induces cell death. This might be important at the end of the
proliferation cycle of Legionella supporting the release of the
pathogen [31]. However, it cannot be excluded that inhibition of
protein synthesis is necessary for establishment of the optimal
environment for Legionella replication. Moreover, protein synthesis
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innate immune response of the host [32].
Eukaryotic EF1A, one of the most abundant proteins in the
cytosol of the eukaryotic cell, is glucosylated at Ser-53, which is
located on a protruding region including helices A* and A’ in the
GTPase domain [31]. This region is lacking in the prokaryotic
homolog of eEF1A, EF-Tu and therefore, Legionella is protected
from its own toxic effector. The canonical function of eEF1A is the
delivery of aminoacyl-tRNAs to the ribosome for protein synthesis.
eEF1A belongs to the superfamily of the GTP binding proteins,
which can bind and hydrolyze GTP. Upon GTP-hydrolysis, the
conformation of the eEF1A switches between an active (GTP-
bound) and inactive (GDP-bound) state. The eEF1A cycle begins
with the GDP/GTP exchange catalyzed by the guanine nucleotide
exchange factor eEF1Ba/b. In the GTP-bound form eEF1A has
high affinity for aa-tRNA and forms a stable ternary complex [33].
The ternary complex protects aa-tRNA from RNases and
spontaneous hydrolysis and facilitates delivery of aa-tRNA to the
decoding site of the ribosome (A site) [33]. eEF1A mediates the
accurate interaction of aa-tRNA anticodon with the codon of the
mRNA in the A site of the ribosome. Codon-anticodon
recognition triggers GTP-hydrolysis by eEF1A, which might affect
the affinity for eEF1A to aminoacyl-tRNA. Consequently eEF1A
dissociates and enters into a new elongation cycle. Apart from the
role in protein synthesis, several non-canonical functions of eEF1A
have been described (e.g. nuclear export activities, turnover of
misfolded proteins, actin cytoskeleton organization and cellular
stress responses [34,35].
Recently, it was shown that Lgt’s are able to glucosylate a
decapeptide (50GKGSFKYAWV59) covering the loop formed by
helices A* and A’ of eEF1A [36]. Interestingly, glucosylation of
this decapeptide was far more efficient than the modification of
purified full length eEF1A, suggesting that a specific conformation
of eEF1A is the preferred substrate of Lgt. Here we show that the
ternary complex conformation of eEF1A consisting of eEF1A,
aminoacyl-tRNA, and GTP is the competent substrate of Lgt’s.
Results
eEF1A is glucosylated during Legionella infection of
macrophages
First, we wanted to show, that eEF1A is glucosylated during
Legionella infection. Therefore, we infected RAW 264.7 macro-
phages with wild type Legionella pneumophila and a mutant deficient
in all Legionella glucosyltransferase genes (AM101) [37]. eEF1A was
extracted and purified by the tight interaction with its guanine
nucleotide exchange factor eEF1Ba purified in E. coli and applied
to mass spectrometric analysis (Fig. 1). Previous analyses revealed
that the interaction of eEF1A with eEF1Ba is not altered by
glucosylation (data not shown). Infection with wild type Legionella
(Fig. 1A), but not with the triple Dlgt mutant (AM101) (Fig.1B)
caused modification of eEF1A by a hexose moiety. MS/MS
analysis revealed Ser-53 as acceptor amino acid and confirmed
recent in vitro data [31]. We observed that the extent of
glucosylation was rather high as compared to in vitro experiments
with purified components, which is usually ,1% [36]. Therefore,
we hypothesized that additional cellular factors are essential to
obtain efficient modification of eEF1A by Lgt’s.
Identification of aa-tRNA and GTP as factors stimulating
eEF1A glucosylation
To search for additional cytosolic factors, we used Lgt3 as a
model glycosyltransferase, because it exhibits the highest inhibitory
potency on protein synthesis in vitro among the three Lgt’s [27].
We first tested whether the extent of glucosylation of purified yeast
eEF1A was affected by the addition of freshly prepared yeast lysate
(Fig. 2). Whereas modification of purified yeast eEF1A was hardly
detected (Fig. 2A, lane 1), the addition of freshly prepared yeast
lysate in combination with the non-hydrolysable GTP analogue
GTPcS, but not with the GDP analogue GDPbS, strongly
enhanced glucosylation (see Fig. 2A, lane 2 and 3). The same effect
was observed with GTP and GDP (data not shown). The addition
of GTPcS or GDPbS in the reaction mixture without yeast cell
extract had no effect (Fig. 2A, lane 4 and 5). Therefore, we
concluded that an additional factor present in cell extracts is
required. eEF1Ba, the guanine nucleotide exchange factor of
eEF1A was shown to form a tight complex with eEF1A [38,39].
However, Lgt3-induced glucosylation could not be detected with
the purified eEF1ANeEF1Ba complex (Fig. 2A, lane 6).
To isolate the supposed factor from yeast cell lysate that
activated the glucosylation, we used cell fractionation. When we
depleted yeast cytosol fractions from proteins by phenol/
chloroform extraction and added the extract (P/C extract) to the
glucosyltransferase reaction, the glucosylation of eEF1A was
restored. The effect was slightly increased by GDPbS (Fig. 2A,
lane 7) but strongly increased in the presence of GTPcS (Fig. 2A,
lane 8). Preincubation of yeast P/C extract or yeast cell extract
with RNase A impaired Lgt3-catalyzed glucosylation of eEF1A
(Fig. 2B). All these results suggested a RNA component as the
stimulating factor for the reaction. As aa-tRNA, in addition to
GTP is a well-known eEF1A ligand, we tested the effect on the
glucosyltransferase reaction of purified yeast tRNA
Phe and Phe-
tRNA
Phe (Fig. 2C). Strikingly, eEF1A-glucosylation was strongly
enhanced by the addition of Phe-tRNA
Phe in combination with
GTPcS (Fig. 2C, lane 1). Uncharged tRNA
Phe could not stimulate
glucosylation (Fig. 2C, lane 2) and also Phe-tRNA
Phe in
combination with GDPbS was not able to stimulate glucosylation
(Fig. 2C, lane 3).
To confirm the finding that aa-tRNA but not uncharged tRNA
or any additional contaminant in the reaction mixture facilitates
glucosylation, we monitored the dependence of the reaction on the
addition of phenylalanine tRNA-synthetase (PheRS). Efficient Lgt-
induced glucosylation of eEF1A depended on the presence of
PheRS, suggesting the requirement of synthesis of Phe-tRNA
Phe
(Fig. 3A), whereas in the absence of PheRS, eEF1A glucosylation
was hardly detectable. These data suggested that binding of aa-
tRNA to eEF1A induces a conformational change, which allows
efficient glucosylation by Lgt3.
Next, we tested whether catalytic amounts of aa-tRNA would be
sufficient to induce glucosylation of eEF1A by Lgt3. The rate of
glucosylation of yeast eEF1A increased with the addition of
increasing amounts of HPLC-purified Phe-tRNA
Phe and reached
maximum velocity at 3 mM, the equimolar ratio of aa-tRNA and
eEF1A (Fig. 3B). These results strongly suggested that the aa-
tRNA?GTP?eEF1A ternary complex, rather than eEF1A alone, is
the bona fide substrate of the Lgt.
To quantify the stimulatory effect of the ternary complex on
Lgt3-catalyzed glucosylation of eEF1A, we compared initial
velocities of the reaction with yeast eEF1A in the presence and
absence of Phe-tRNA
Phe and tRNA
Phe (Fig. 4A). Only the
eEF1A?GTP?Phe-tRNA
Phe ternary complex was effectively mod-
ified. The kcat-value for glucosylation of yeast ternary complex was
150-fold higher compared to yeast eEF1A incubated with Phe-
tRNA
Phe and GDP (Table 1). Thus, the addition of aa-tRNA and
GTP enabled a quantitative glucosylation of eEF1A. This was
proven by glucosylation of the ternary complex of yeast eEF1A
with unlabeled UDP-glucose followed by purification of the
modified eEF1A by affinity chromatography and subsequent
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(Fig. 4C).
To analyze the effect of Phe-tRNA
Phe on Lgt-catalyzed
glucosylation of mammalian EF1A, we purified native eEF1A
from mouse liver. The glucosylation of mouse eEF1A was even
more prominent and enhanced 590-fold in the presence of aa-
tRNA and GTP (Fig. 4B and Table 1).
Because the data emphasized the essential role of amino acid
attached tRNA in enhancing glucosylation of eEF1A, we tested
whether the effect could be reproduced in the presence of aa-
tRNA other than Phe-tRNA
Phe. We prepared His-tRNA
His using
recombinant histidyl-tRNA-synthetase, allowed ternary complex
formation with yeast eEF1A and GTPcS and analyzed the
complex in glucosyltransferase reactions with Lgt3. His-tRNA
His
stimulated glucosylation of yeast eEF1A very efficiently and the
degree of stimulation was similar to that of Phe-tRNA
Phe (Fig. 4D).
Next, we tested the other known Legionella glucosyltransferases
(Lgt1 and 2) with the ternary complex of yeast eEF1A and
determined the initial velocities with Phe-tRNA
Phe in the presence
of GTP or GDP. In line with Lgt3, the kcat-values for Lgt1 and 2
increased from 1.760.1 to 128.2619.9 h
21 and 0.560.1 to
33.560.9 h
21, respectively, when yeast eEF1A?GTP?Phe-
tRNA
Phe ternary complex was used as a substrate (Table 1).
These results support the notion that eEF1A ternary complex is
the preferred substrate for Legionella glucosyltransferases.
Full length eEF1A is essential for aa-tRNA-dependent
stimulation of glucosylation
The crystal structure of the ternary complex of eEF1A with
GTP and aa-tRNA is not known, but it is assumed that the
interaction is similar to that found in the bacterial homolog
complex [40]. The interaction surface of EF-Tu with aa-tRNA
covers mainly domain II and domain III (Fig. 5A, right structure).
The aminoacyl terminus of aa-tRNA is bound in between the G
domain and domain II (Fig. 5A, red spheres) [41,42]. To test
whether isolated fragments of eEF1A are sufficient to bind aa-
Figure 2. Analysis of yeast eEF1A (yEF1A) glucosylation by Lgt3. (A) Glucosyltransferase reaction was performed with Lgt3 (140 nM) and
yeast eEF1A (3 mM) with UDP-[
14C]glucose (10 mM) for 15 min at 30uC in the presence of either GDPbS (75 mM) or GTPcS (75 mM) and the following
components: purified yeast eEF1A (control, lane 1), yEF1A with freshly prepared yeast cell lysate (30 mg) (lane 2 and 3), yEF1A in the presence of
GDPbS (75 mM) (lane 4) or GTPcS (75 mM) (lane 5), yEF1A?yEF1Ba complex (3 mM each) (lane 6), yEF1A with 5 ml phenol/chloroform extract (P/C
extract) prepared from yeast lysate (lane 7 and 8). Prior to glucosyltransferase reaction, the mixtures were preincubated for 10 min at RT. Products
were separated by SDS-PAGE and glucosylated eEF1A was visualized by autoradiography. (B) Effect of the RNase A treatment. Glucosylation of 3 mM
eEF1A by Lgt3 (140 nM) in yeast lysate or with P/C-extract was performed after treatment with RNase A (1.6 mg/ml) for 10 min at RT. (C)
Glucosyltransferase reaction was performed as in (A) with the addition of Phe-tRNA
Phe or uncharged yeast tRNA
Phe (1 mM) in the presence of GDPbS
(75 mM) or GTPcS (75 mM), respectively.
doi:10.1371/journal.pone.0029525.g002
Figure 1. eEF1A is glucosylated during L. pneumophila infection at Ser53. Mammalian eEF1A was isolated by eEF1Ba-affinity
chromatography from RAW 264.7 macrophages infected with L. pneumophila wild type (A), L. pneumophila triple Dlgt-mutant AM101 (B) and
uninfected cells (C). LC-MS/MS (Q-TOF) analysis revealed the extracted ion chromatograms shown. The peak at m/z=642.3 (2+) belongs to the
chymotryptic peptide 43-EKEFAAEMGKGSF-54 of eEF1A without modification. This was identified by MS/MS with a Mascot peptide Score of 72. The
peptide from Legionella infected cells is partially shifted to m/z=723.3 (2+) indicating modification by hexose (162.053 Da). The chromatograms were
scanned for peptides with m/z=642.302610 ppm (2+) (shown in blue) and peptides with m/z=723.331610 ppm (2+) (shown in red). The hexose-
modified form of the peptide EKEFAAEMGKGSF was exclusively detected in Legionella infected cells. Partial neutral loss of dehydrohexose (162.053
Da), typical for hexose-modified peptides, is observed already without additional collision energy in the MS scan (see Figure 1A, blue peak at
14 minutes). (D) Collision-induced dissociation MS/MS spectrum of the glucosylated peptide EKEFAAEMGKGSF (precursor m/z=723.3 (2+); peak
intensity=2.5610
4; retention time 14.06 min) identified Ser-53 as the acceptor amino acid for glucosylation (Mascot peptide Score of 60).
doi:10.1371/journal.pone.0029525.g001
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several yeast eEF1A truncation mutants (Fig. 5A). The proteins
p38 (eEF1A without domain III (aa1-349)), p29 (G domain (aa1-
265)) and p5 (5 kDa peptide, comprising the helix-loop-helix
region (aa29-73)) were purified and tested as substrates in the
presence and absence of aa-tRNA (Fig. 5B). Except for the full-
length eEF1A, only p38, which harbors the G domain and domain
II, was more efficiently modified in the presence of aa-tRNA than
in its absence (Fig. 5B insert), albeit to a much lower extent than
the wild type eEF1A. Thus, full length eEF1A and an intact
interface of the G domain and domain II seem to be necessary to
allow aa-tRNA-dependent glucosylation. Belyi and co-workers
demonstrated that in the absence of aa-tRNA, peptide fragments
of eEF1A of a size down to 45 amino acid residues (aa29-72,
fragment p5) or even a 10 amino acid fragment (aa50-59) were
more efficiently glucosylated than purified full length eEF1A [36].
However, in direct comparison the ternary complex of eEF1A is
more efficiently modified in the presence of aa-tRNA than the
smaller fragment p5 (Fig. 5C) and is thus the preferred substrate of
the reaction.
Aminoacyl-tRNA does not directly interact with
Legionella glucosyltransferases
The fact that glucosylation of the eEF1A peptide fragments p5
or p29 were not influenced by the addition of aa-tRNA ruled out
the possibility that aa-tRNA stimulated the glucosyltransferase
directly (Fig. 5B). In addition, we were not able to precipitate
[
14C]Phe-tRNA
Phe by Lgt3 (not shown). Thus, we could not detect
a direct effect of aa-tRNA on the enzyme activity in the absence of
eEF1A.
The ternary complex formation is not generating
additional acceptor sites for glucosylation
To exclude that aa-tRNA binding generated new glucosylation
sites in eEF1A in addition to Ser-53, we tested the modification
with a S53A mutation of eEF1A (Fig. 6). The mutation abolished
the glucosylation by Lgt3 in the presence or absence of aa-tRNA.
These results indicated that aa-tRNA binding does not unmask
additional glycosyl acceptor sites apart from Ser-53.
Glucosylation does not impair the interaction between
eEF1A and aa-tRNA
To study whether Lgt3-catalyzed glucosylation of eEF1A has
any effects on the binding of aa-tRNA to eEF1A, we performed an
aa-tRNA protection assay [33]. Here, eEF1A protects aa-tRNA
from spontaneous deacylation within the ternary complex. We
monitored deacylation with radiolabeled [
14C]Phe-tRNA
Phe in a
time course at 37uC. Non-hydrolyzed [
14C]Phe-tRNA
Phe was
quantified after filter-binding by scintillation counting (Fig. 7).
Both native and glucosylated eEF1A protected aa-tRNA from
hydrolysis, whereas non-complexed aa-tRNA was hydrolyzed
almost completely after 60 min of incubation. Thus, glucosylation
does not inhibit the formation of the ternary complex eEF1A with
GTP and aa-tRNA.
Discussion
The members of the Legionella glucosyltransferase family (Lgt 1–
3) modify eEF1A and potently inhibit eukaryotic protein synthesis
in vivo. However, in contrast to the high biological activity of the
enzymes, rate and efficiency of in vitro glucosylation of the purified
eEF1A by recombinant Lgt’s are rather low. Notably, it was shown
that a 45aa peptide, comprising aa29-72 of eEF1A, is more
efficiently modified than full length eEF1A [36], suggesting that a
specific conformation of eEF1A is essential for glucosylation.
Extensive search for additional factors in yeast cell lysate, which
enhanced the efficiency of Lgt-catalyzed glucosylation of eEF1A,
revealed non-proteinaceous cytosolic components, comprising
aminoacyl-tRNA and GTP. A direct effect of aa-tRNA and
GTP on the glucosyltransferase was excluded, because aa-tRNA
was not able to stimulate Lgt-induced glucosylation of a 5 kDa-
peptide substrate, consisting of the helix-loop-helix region of
eEF1A. This indicates that the interaction of the full-length eEF1A
is necessary for induction of the conformational state of eEF1A,
which allows efficient glucosylation. Moreover, we observed that
an equimolar ratio of aa-tRNA and eEF1A is required to obtain
the maximum rate in glucosylation. This suggests that the ternary
complex, consisting of eEF1A, GTP and aa-tRNA, is the
Figure 3. Aa-tRNA stimulates eEF1A glucosylation. (A) Time
courses of the glucosylation of yeast eEF1A (yEF1A) with Lgt3 were
performed in the presence of yeast tRNA (10 mM) and 10 mM UDP-
[
14C]glucose (triangles). Phe-tRNA synthetase was added at time point
zero (black circles) or after 6 min (open circles) as marked by
corresponding arrows.
14C-glucosylation of yEF1A was determined by
SDS-PAGE and autoradiography. Shown curves represent means (6SD)
of three independent experiments. (B) Glucosylation of yEF1A (3 mM) by
Lgt3 (5 nM) was conducted with increasing concentrations of HPLC-
purified [
14C]Phe-tRNA
Phe. Initial glucosylation rates were determined
after incubation for 10 min at 30uC in the presence of 50 mM GTPcS,
10 mM PEP, 0.1 mg/ml pyruvate kinase and 10 mM UDP-[
14C]glucose as
the donor substrate. Radiolabeled aa-tRNA could be distinguished from
14C-glucosylated yEF1A by separation of the products by SDS-PAGE.
Data shown represent velocities of yEF1A glucosylation and are given as
means (6SD) of three independent experiments.
doi:10.1371/journal.pone.0029525.g003
Legionella Lgt’s Glucosylate aa-tRNA-Charged eEF1A
PLoS ONE | www.plosone.org 5 December 2011 | Volume 6 | Issue 12 | e29525competent substrate for Lgt’s. Kinetic measurements of glucosyla-
tion of yeast and mammalian EF1A by Lgt3 revealed that kcat-
values increased 150 to 580-fold in the presence of aa-tRNA and
GTP.
The interaction of the prokaryotic paralogue EF-Tu with aa-
tRNA is well studied and its affinity seems to be similar for all aa-
tRNAs. This general affinity was shown to depend on both sides,
the nature of the esterified amino acid and the tRNA body,
resulting in comparable affinity by ‘‘thermodynamic compensa-
tion’’ [43–48]. Our results highlight the importance of amino acids
attached to tRNA, because uncharged tRNA was ineffective in
stimulation of eEF1A glucosylation. Using histidyl-tRNA and
phenylalanyl-tRNA, respectively, in complex with yeast eEF1A
and GTP, we showed that the attached individual amino acid and
Figure 4. Kinetics of eEF1A glucosylation by Lgt3. Time courses of glucosylation of purified yeast eEF1A (yEF1A) (A) or mouse eEF1A (mEF1A)
(B) by Lgt3 in the absence (triangles) or presence of Phe-tRNA
Phe (filled circles) or uncharged tRNA
Phe (open circles). The glucosylation reactions and
analyses were performed under the conditions as described in Figure 1. Values of
14C-glucose incorporation are shown as the mean (6SD) of at least
three independent experiments. The inserts show representative radioimages. (C) eEF1A ternary complex is quantitatively glucosylated by Lgt3. Yeast
eEF1A (20 mM) was glucosylated by Lgt3 (5 mM) with Phe-tRNA
Phe (20 mM) and GTP (75 mM) in the absence (lane 1) or presence (lane 2) of cold UDP-
glucose (1 mM). Modified and unmodified yEF1A were separated by His-eEF1Ba affinity purification as described in Materials and Methods.
Thereafter, the isolated eEF1A (3 mM each) was subjected to second glucosylation reaction with radiolabeled UDP-[
14C]glucose in presence of Phe-
tRNA
Phe (1 mM) and GTP (75 mM). The Coomassie gel and the autoradiogram are shown. (D) Glucosylation of yEF1A (2 mM) was performed in the
presence of His-tRNA
His or uncharged yeast tRNA with Lgt3 (140 nM).
doi:10.1371/journal.pone.0029525.g004
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one base pair in the case of His-tRNA
His, are not crucial for
glucosylation. Of course, we cannot exclude that other types of aa-
tRNA show specific effects on activation of glucosylation not
observed with Phe-tRNA
Phe or His-tRNA
His.
Gromadski et al. investigated the affinity of Phe-tRNA
Phe for
eEF1ANGTP and obtained a Kd-value of 3 nM, whereas binding of
Phe-tRNA
Phe to the GDP-bound eEF1A was not measurable [33].
The affinity of GTP or GDP to eEF1A was comparable and their
binding was suggested not to induce major structural rearrange-
ments at least in the structural complex with eEF1Ba [39]. These
observations are consistent with the glucosylation behavior of
Lgt3. Neither the GTP- nor the GDP-bound form of yeast eEF1A
was an efficient substrate for glucosylation, indicating failure to
generate the correct target conformation. The same was true for
uncharged tRNA, which reportedly has a very low affinity to
GTP-bound eEF1A [33]. Thus, the mixture of eEF1A, GTP or
GDP and uncharged tRNA was not efficiently modified by Lgt3.
As our results demonstrate that addition of aa-tRNA and GTP
(or GTPcS) to in vitro enzymatic assays largely increases the rate
and efficiency of glucosylation of eEF1A by Lgt’s, it is likely that
major conformational rearrangements of eEF1A occur upon the
binding of aa-tRNA and GTP, which form a stable ternary
complex (eEF1ANGTPNaa-tRNA). We suggest that such an
interaction induces structural changes in the G domain, particular
in the helix-loop-helix region, harboring acceptor amino acid Ser-
53, which allow efficient transfer of the glucose moiety to the
substrate. The recently published crystal structure of archaeal
EF1A from Aeropyrum pernix in complex with Pelota, an interaction
partner recognizing stalled ribosomes containing defective mRNA,
gave first insights into putative structural rearrangements of the G
domain of eEF1A [49]. Pelota was shown to mimic charged aa-
tRNA structurally and its binding to archaeal EF1A induces
remarkable changes in the helix A*-helix A’ region, involving the
conserved putative glucosyl acceptor amino acid (this is Ser-52 in
the case of this organism).
Analysis of the functional protection of aa-tRNA by interaction
with eEF1A revealed that glucosylation at Ser-53 of eEF1A does
not influence the formation as well as the stability of the ternary
complex (see Fig. 7). This suggests that the interaction of
glucosylated eEF1A with aa-tRNA is well preserved under these
conditions. Therefore, we speculate that inhibition of protein
biosynthesis, which occurs as a result of glucosylation of eEF1A,
takes place directly at the ribosome.
The functional consequences of eEF1A glucosylation and
inhibition of protein synthesis during the infection process of
Legionella is not completely understood. It might be that inhibition
of protein synthesis is essential for Legionella-induced cell death and
pathogen release after replication [29,31]. Another possibility is
the involvement of Lgt’s in ‘‘fine tuning’’ of the host metabolism to
optimize the host environment for replication. Also protein
synthesis inhibition might cause an altered host cell defence
mechanism by reduced or elevated factors of the innate immune
system [32,50] or an altered host stress response [35,51].More-
over, modification of the non-canonical functions of eEF1A (e.g.
influence on the actin cytoskeleton or on subcellular organization
[34]), which are are still controversely discussed, might also play an
important role in the infection process. In conclusion, our data
suggest that full length eEF1A binds aa-tRNA and GTP to form
the competent substrate conformation required for glucosylation
by Lgt’s. By selecting the ternary complex of eEF1A, aa-tRNA and
GTP as the preferred substrate for Lgt-induced modification
within the abundant pool of eEF1A inside cells, the bacterial
effectors increase their efficiency to inhibit protein synthesis of
their hosts.
Materials and Methods
Materials and plasmids
Escherichia coli strain BL21 (DE3) and Saccharomyces cerevisiae
MH272-3fa (ura3 leu2 his3 trp1 ade2) were used for protein
expression. L. pneumophila serogroup 1 Philadelphia I and the strain
L. pneumophila AM101 deficient in all lgt genes (Dlgt1, Dlgt3,
lgt2::kan
r) were used for infection studies. The AM101 strain was
kindly provided by Dr. Craig Roy (Yale University, New Haven,
USA). Murine RAW 264.7 macrophages were used for infection
studies. Expression vector pGEX-4T was from GE Healthcare
(Freiburg, Germany), pET28a vector from Novagen (Madison,
WI). pBC KS (+) and pBluescript KS (+) vectors were from
Stratagene (Waldbronn, Germany). For expression of yeast
proteins pRS313, pRS423, and YCpLac22 vectors were used.
DNA-modifying enzymes were purchased from Fermentas (St.
Leon-Rot, Germany). UDP-[
14C]glucose was from American
Radiolabeled Chemicals (St. Louis, USA). PfuII Turbo DNA
Polymerase was from Stratagene and Phusion
TM, and High-
Fidelity DNA Polymerase from New England Biolabs (Ipswich).
All other reagents were of analytical grade and purchased from
commercial sources.
Cloning of genes for bacterial expression
The genes lgt1 (lpg1368), lgt2 (lpg2862), and lgt3 (lpg1488) were
amplified with PfuII Turbo from the genomic DNA of L.
pneumophila strain Philadelphia-1 and cloned into a modified
pET28a TEV as published [27]. The p4T2-403G (p5) plasmid,
coding for GST-fused 45aa catalytic fragment of Tef1p was
constructed as described previously [36]. The sequences of
corresponding plasmids were confirmed by sequencing (GATC
Inc., Konstanz, Germany).
Cloning of genes for yeast expression
Initially, the coding sequence of yeast eEF1A with ,500 nts
upstream and downstream regions was amplified from S. cerevisiae
chromosomal DNA using primers #518/#492 (Table S1), the
product digested with BamHI/SalI restriction endonucleases and
ligated into similarly digested pRS313 [52], producing plasmid
Table 1. kcat-values for glucosylation of eEF1A ternary
complex by Lgt’s.
Transferase Substrate kcat [h
21]
Lgt3 yEF1ANGTPNPhe-tRNA
Phe 381.7626.7
Lgt3 yEF1ANGDPNPhe-tRNA
Phe 2.560.1
Lgt3 mEF1ANGTPNPhe-tRNA
Phe 340.5619.5
Lgt3 mEF1ANGDPNPhe-tRNA
Phe 0.660.1
Lgt1 yEF1ANGTPNPhe-tRNA
Phe 128.2619.9
Lgt1 yEF1ANGDPNPhe-tRNA
Phe 1.760.1
Lgt2 yEF1ANGTPNPhe-tRNA
Phe 33.560.9
Lgt2 yEF1ANGDPNPhe-tRNA
Phe 0.560.1
Yeast eEF1A (yEF1A) and mouse eEF1A (mEF1A) were incubated for 10 min with
an equimolar concentration of HPLC-purified Phe-tRNA
Phe and GTPcS or GDPbS
(50 mM) as indicated. Afterwards the complexes were subjected to in vitro
glucosyltransferase reactions with UDP-[
14C]glucose (10 mM) and 5 nM Lgt1, 2
and 3. The data were autoradiographically quantified using ImageQuant. Data
are given as the mean (6SD) of triplicates of 5 min time points.
doi:10.1371/journal.pone.0029525.t001
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eEF1A truncations used (upper panel). Lower panel: Structural models deduced from the crystal structure of eEF1A in complex with eEF1B (pdb 1IJF).
For visualization of the region of aminoacyl-tRNA binding the crystal structure of the ternary complex of EF-TuNGTPNPhe-tRNA
Phe (pdb 1TTT) is
depicted on the right. The GTPase domain (G domain) is shaded in orange, domain II in blue, domain III in green, and tRNA is shown in brown. The
aminoacyl residue of aa-tRNA located between the G domain and domain II is shown as red spheres. GDP or GTP is depicted as black sticks. The
position of glucosyl acceptor serine 53 is shown in red and marked with arrowheads. The figures were prepared using PyMOL (www.pymol.org). (B)
Glucosylation of different truncation fragments of yeast eEF1A (yEF1A) (3 mM) was performed with Lgt3 (140 nM) in the presence of Phe-tRNA
Phe or
uncharged tRNA
Phe (each 1 mM), respectively. Constructs used: p38 represent eEF1A without domain III (aa1-349), p29 harbors the G domain (aa1-
265), and p5 is a 5 kDa-peptide, comprising the helix-loop-helix region (aa29-73) of yEF1A. Glucosylation was performed under standard conditions
for 15 min at 30uC. The insert shows the induction of Lgt3-catalyzed glucosylation of the fragments by Phe-tRNA
Phe. (C) Time courses of in vitro
glucosylation of yEF1A in complex with GTP and Phe-tRNA
Phe (open circles), the 45 amino acid fragment of yEF1A p5 (filled squares), yEF1A (filled
circles), and yEF1A with uncharged tRNA
Phe (open triangles) by Lgt3. All data given represent means (6SD) of three independent experiments.
doi:10.1371/journal.pone.0029525.g005
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corresponding sequences from yeast chromosomal DNA with
primers #649/#650 and #651/#492, digesting the products
with NcoI/EcoRI and EcoRI/SalI and subsequently ligating them
sequentially into pET28a, thus generating a plasmid p672. The
final construct, encoding a C-terminally 6xHis-tagged yeast
eEF1A was produced by replacing a part of p572 with the
NcoI/SalI fragment from p672 thus generating plasmid p689. To
clone the gene coding for the C-terminally 6-His-tagged G
domain, the gene of yeast eEF1A with upstream and downstream
regions (see cloning p572) was subcloned into YCpLac22 plasmid
[53] using BamHI/SalI restriction sites (plasmid p553). Then, the
SacI/XbaI fragment containing coding sequence of the G domain
with upstream promoter region was ligated into the pBluescript
KS (+) vector (p681). To attach a 6xHis-tag, the G domain-coding
sequence was cut out from p681 using SacI/HindIII and ligated
into pET28b (p682). Finally, the plasmid was amplified with the
primers #16/#660, the amplicon digested with SacI/SalI and
ligated into pRS423 vector [52] to generate the plasmid p710. To
construct the C-terminally 6xHis-tagged yeast eEF1A S53A
mutant, the region coding for the Ser-53-containing peptide was
excised out of p553 with endonucleases SacI/ClaI and ligated into
the pBC KS (+) vector, generating plasmid p574. QuikChange
(Stratagene) site-directed mutagenesis technology was applied to
this construct using primers #542/#543, generating the S53A
substitution (plasmid p575). Subsequently, wild type coding region
in the plasmid p689 (C-terminally 6xHis-tagged yeast eEF1A, see
above) was substituted with the mutated sequence using SacI/ClaI
insert of p575, to obtain the plasmid p726. For yeast transforma-
tion, standard genetic techniques were applied [54].
Purification of recombinant proteins
E. coli BL21(DE3) transformed with the desired plasmid was
grown in the LB broth supplemented with ampicillin or
kanamycin on a shaker at 37uC until A600=0.8. Protein
expression from the pET28-based plasmids was induced by
1 mM isopropyl-b-D-thiogalactopyranoside (Roth, Karlsruhe,
Germany) for 4–5 h at 22uC, and for pGEX-based constructs
with 0.2 mM isopropyl-b-D-thiogalactopyranoside at 37uC for
3h .
Bacterial cells were harvested by centrifugation at 6,0006g for
15 min, resuspended in lysis buffer (20 mM Tris–HCl (pH 7.4),
150 mM NaCl, 25 mM imidazole, 30 mg/ml DNase I, 10 mM b-
mercaptoethanol, 1 mg/ml lysozyme and Proteinase Inhibitor
Cocktail (Roche)) and lysed by French press or sonication. The
cleared lysate was subjected to chromatography on a glutathione-
Sepharose Fast Flow or nickel-equilibrated chelating Sepharose
Fast Flow column according to the manufacturer’s instructions
(GE Healthcare). Bound proteins were eluted with 10 mM
reduced glutathione, 0.5 M imidazole or thrombin treatment,
depending on the construct used.
For the production of recombinant yeast 6xHis-containing
protein, S. cerevisiae was grown overnight in a medium containing
0.67% yeast nitrogen base with ammonium sulfate without amino
acids (Difco, USA), 100 mg/ml of L-leucine and 20 mg/ml of each
L-tryptophan, uracil, and adenine, and 2% glucose. Yeast cells were
disrupted by Oscillating Mill MM 400 (Retsch, Germany). Cleared
extracts were subjected to HisTrap FF chromatography using A ¨kta
Purifier (GE Healthcare). Yeast eEF1A (yEF1A) and mammalian
eEF1A (mEF1A) were purified based on their interaction with His-
tagged yEF1Ba as described previously [38]. In brief, yEF1Ba
expressed in E. coli and purified on a HisTrap HP column was used
to pulldown eEF1A from the commercial baker’s yeast lysate or
mouse liver tissue homogenate. The complex was applied onto a
HisTrap HP column with eEF1A lysis buffer (100 mM Tris-HCl
pH 7.6 at 6uC, 200 mM KCl, 5 mM MgCl2, 10% glycerol,
0.5 mM, b-mercaptoethanol, 20 mM imidazole, 0.1 mM PMSF,
and protease inhibitor cocktail). The eEF1A?EF1Ba complex was
eluted with a linear gradient of 20 to 250 mM imidazole. eEF1A
was released from the complex by incubation with 100 mM GDP
and applied onto Mono Q column (GE Healthcare, Freiburg,
Germany) followed by further purification on a Resource S column
(GE Healthcare) and dialysis against a final storage buffer (20 mM
Tris-HCl (pH 7.6), 150 mM KCl, 5 mM MgCl2, 0.5 mM dithio-
threitol, 15 mM GDP, and 25% glycerol). Glucosylated eEF1A was
purified similarly.
Aminoacyl-tRNA synthesis
Phe-tRNA
Phe was obtained by incubation of 5 mM purified
yeast tRNA
Phe (Sigma, St. Louis, USA) and yeast phenylalanyl-
Figure 6. Ser-53 in eEF1A is the unique glucosylation site in the
presence of Phe-tRNA
Phe. Wild type yeast eEF1A (yEF1A) and the
yeast eEF1A S53A mutant (yEF1A S53A; each 1 mM) were subjected to
an in vitro glucosylation reaction with Lgt3 (140 nM) in the presence or
absence of Phe-tRNA
Phe.
doi:10.1371/journal.pone.0029525.g006
Figure 7. Effect of glucosylation on the stability of the ternary
complex. Aminoacyl-tRNA stability towards hydrolysis was determined
with 3 mM yeast eEF1A (yEF1A, filled circles) or glucosylated yeast eEF1A
(yEF1A, open circles), 1 mM GTP and 1 mM[
14C]Phe-tRNA
Phe for 60 min.
As a control [
14C]Phe-tRNA
Phe was incubated without eEF1A (triangles).
Non-hydrolyzed [
14C]Phe-tRNA
Phe was quantified by filter binding assay
and scintillation counting.
doi:10.1371/journal.pone.0029525.g007
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14C]-
phenylalanine (868 dpm/pmol) or 100 mM unlabeled phenylal-
anine in charging buffer (20 mM Hepes/KOH (pH 7.3), 2.5 mM
spermidine trihydrochloride, 1 mM ATP, 5 mM MgCH3CO2,
1m MD T Ta n d1 0 0m MN H 4Cl) for 20 min at 37uC. The
extent of aminoacylation was determined by scintillation
counting after trichloroacetic acid precipitation and filtration
through GF/C filters. HPLC purified [
14C]Phe-tRNA
Phe was
prepared as described [56]. Histidyl-tRNA
His was prepared by
charging yeast tRNA
His in the yeast tRNA mixture (Sigma) with
histidyl-tRNA synthetase (HisRS) (MY Biosource, San Diego,
USA). Ternary complex was formed after incubation of the
components for 10 min at room temperature in the presence of
75 mM GTP, 0.1 mg/ml pyruvate kinase and 10 mM phospho-
enolpyruvate. After ternary complex formation of yeast eEF1A,
GTP and His-tRNA
His, the remaining uncharged tRNA was
digested with RNase A for 10 min at 4uC prior to glucosylation
reaction.
Glucosyltransferase assay
Yeast cell lysate used as crude substrate for Lgt was prepared
by lysis of a pelleted yeast culture with an Oscillating Mill MM
400 (Retsch, Germany). Glucosylation was performed with 140
nM (if not otherwise noted) recombinant His-tagged Lgt1, 2, and
3 and crude eukaryotic cell extract or recombinant substrates
(3 mM) in a total volume of 20 ml. The standard reaction
proceeded at 30uC for 15 min in 20 mM Tris-HCl (pH 7.5),
150 mM NaCl, 1 mM MnCl2,a n d1 0mM UDP-[
14C]glucose.
The reaction was stopped by the addition of SDS-sample buffer
and heating at 95uC for 5 min. Subsequently, samples were
subjected to SDS-PAGE. Proteins were stained with Coomassie
and radiolabeled bands were analyzed by PhosphorImaging and
quantification with ImageQuant 5.2 (GE Healthcare, Freiburg,
Germany).
Aa-tRNA protection assay
Yeast eEF1A (20 mM) was glucosylated by 5 mM Lgt3 for 5 min
at 37uC in the presence of 1 mM UDP-glucose, GTP, tRNA
Phe,
phenylalanine, PheRS, phosphoenolpyruvate, and pyruvate kinase
as described above. Modified and unmodified yeast eEF1A was
purified from TEV-cleaved Lgt3 by His-yEF1Ba affinity chroma-
tography (see Purification of Recombinant Proteins). The formation of
the ternary complex was obtained by incubation of 3 mM
glucosylated or non-glucosylated yeast eEF1A with 1 mM
[
14C]Phe-tRNA
Phe from yeast, 1 mM GTP, 3 mM phosphoenol-
pyruvate, 1 mM ATP, 7 mM MgCl2 and 1% of pyruvate kinase in
70 ml of TAKM7 buffer (50 mM Tris-HCl (pH 7.5), 70 mM
NH4Cl, 7 mM MgCl2 and 30 mM KCl) as described [33]. The
reaction was carried out at 37uC and at various time points 265 ml
of the reaction solution was precipitated by 10% trichloroacetic
acid and transferred onto nitrocellulose filters. After washing with
5% trichloroacetic acid non-hydrolyzed [
14C]Phe-tRNA
Phe was
measured by scintillation counting.
Cell culture
Raw 264.7 macrophages were cultivated in Dulbeccos MEM
modified Eagles medium supplemented with 10% fetal calf serum
(FCS) and penicillin/streptavidine (Biochrom, Berlin, Germany).
Cell lines were cultured at 37 uCi n5 %C O 2. The Legionella strains
were grown on charcoal-yeast extract agar plates [31] or PP#3-
liquid medium (per liter: 15 g proteose peptone no. 3 (Difco), 10 g
ACES-buffer, 0.4 g L-cysteine H2O, 1 g a-ketoglutarate, (pH 6.9)).
Kanamycin 25 mg/ml was applied where necessary.
Isolation of in vivo glucosylated eEF1A
6x100 mm dishes RAW 264.7 macrophages (80% confluency)
were incubated for 1 h in DMEM-medium without additives.
Legionella strains were cultivated on charcoal plates and liquid
medium to an OD600 of 2.0. Subsequently, RAW macrophages
were infected with L. pneumophila strains indicated (multiplicity of
infection=100). After incubation for 5 h under cell culture
conditions, macrophages were washed extensively and scraped
off with lysis buffer (50 mM Tris (pH 7.4), 100 mM NaCl, 1 mM
MgCl2, 1 mM PMSF and complete protease inhibitor mix
(Roche)) and lysed by 10 strokes with a 1 ml syringe equipped
with a G26 needle. After centrifugation (17.900 x g, 10 min), the
post-nuclear supernatant was incubated with 100 mg His-tagged
eEF1Ba for 15 min on ice followed by Ni
2+-affinity chromatog-
raphy. After elution with 500 mM imidazole, proteins were
reduced by dithiothreitol treatment, alkylated with iodoacetamide,
and separated by 12.5% SDS-PAGE. The corresponding bands of
eEF1A were excised and analyzed by mass spectrometry.
LC-MS/MS analysis
For in-gel digestion the excised gel bands were destained with 30%
ACN, shrunk with 100% ACN, and dried in a Vacuum Concentrator
(Concentrator 5301, Eppendorf, Hamburg, Germany). Digests with
chymotrypsin was performed overnight at 25uCi n0 . 1MN H 4HCO3
(pH 8). About 0.1 mg of protease was used for one gel band. Peptides
were extracted from the gel slicesw i t h5 %f o r m i ca c i d .A l lL C - M S /
MS analyses were performed on a Q-TOF mass spectrometer (Agilent
6520, Agilent Technologies) coupled to a 1200 Agilent nanoflow
system via a HPLC-Chip cube ESI interface. Peptides were separated
on a HPLC-Chip with an analytical column of 75 mmi . d .a n d
150 mm length and a 40-nL trap column, both packed with Zorbax
300SB C-18 (5 mm particle size). Peptides were eluted with a linear
acetonitrile gradient with 1%/min at a flow rate of 300 nl/min (starting
with 3% acetonitrile). The Q-TOF was operated in the 2 GHz
extended dynamic range mode. MS/MS analyses were performed
using data-dependent acquisition mode. After a MS scan (2 spectra/s),
a maximum of three peptides were selected for MS/MS (2 spectra/s).
Singly charged precursor ions were excluded from selection. Internal
calibration was applied. Mascot Distiller 2.3 was used for raw data
processing and for generating peak lists, essentially with standard
settings for the Agilent Q-TOF. Mascot Server 2.3 was used for
database searching with the following parameters: peptide mass
tolerance: 20 ppm, MS/MS mass tolerance: 0.05 Da, enzyme:
‘‘chymotrypsin’’ with 2 uncleaved sites allowed, variable modifications:
Carbamidomethyl (C), Gln-.pyroGlu (N-term. Q), oxidation (M) and
Hexose (ST). For protein identification SwissProt protein database was
used.
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